To establish our hypothesis, we analyzed putative mechanisms and the lncRNA DLEU2 functions in BC cells to support our findings, and we showed that lncRNA DLEU2 affected BC cell proliferation and resistance to the chemotherapeutic drug cisplatin in vitro. Here, DLEU2 is linked to breast cancer.